At Douglas & London, our dedicated trial attorneys are committed to representing the rights of our clients against major corporations. We handle cases for clients throughout the world, and no case or defendant is too difficult for us to tackle. The Ortho Evra® patch lawyers at Douglas & London will handle your case from start to finish. We will not refer your potential case to another attorney or law firm. We thoroughly investigate each case using our team of experts in all fields, including medical specialists, FDA experts, and forensic technicians. If you suspect you have been injured as the result of Ortho Evra® use, contact our birth control patch lawyers today.
Our firm’s involvement and participation in the Zyprexa® product liability litigation yielded a $690 million settlement, where law firm partner, Michael A. London played a pivotal role, holding the position of Vice-Chair of the Plaintiffs' Steering Committee
Partner and famed trial attorney Gary J. Douglas' landmark verdict, the first in the history of the State of New York against the tobacco industry for the death of a 58-year-old smoker
For a 16-year-old teen whose skull was fractured when he was struck by a train in a New York City subway station
Contact our Ortho Evra® patch lawyers for additional lawsuit information.
On August 18, 2005, Douglas & London, P.C. filed the nation’s first Ortho Evra® class action lawsuit against Ortho-McNeil Pharmaceutical, Inc., Johnson & Johnson Pharmaceutical Research & Development, L.L.C., and Johnson & Johnson, for injuries caused by the use of the Ortho Evra® birth control patch. Serious side effects have been linked to the Ortho Evra® patch, including blood clots, heart attack, stroke, coma, and death. This lawsuit is being filed on behalf of victims who have suffered injury or death after using the Ortho Evra® patch. The trial lawyers at Douglas & London are fully prepared to prosecute this Ortho Evra® lawsuit in federal court and will not refer cases to other firms.
November 11, 2005
The FDA approved updated labeling for the Ortho Evra® contraceptive patch to warn healthcare providers and patients that the product exposes women to higher levels of estrogen than most birth control pills. Ortho Evra® was the first skin patch approved for birth control.
The new warning states that women who use Ortho Evra® are exposed to about 60 percent more estrogen than if they were taking a typical birth control pill containing 35 micrograms of estrogen.
Approved by the FDA in fall 2001, Ortho Evra® is a birth control patch that has been prescribed to more than five million women. Aggressively marketed to consumers and doctors as a safe and convenient alternative to oral birth control pills, Ortho Evra® has become the most popular prescribed form of birth control in the United States. Manufactured by Ortho-McNeil Pharmaceutical, Inc., a division of Johnson & Johnson, the patch has become associated with a significantly higher rate of serious health risks than other forms of birth control. For this reason, the Ortho Evra® patch is now the target of lawsuits filed on behalf of victims who have suffered serious injury or death after using the patch. At Douglas & London, P.C., our Ortho Evra® patch lawyers filed the first nationwide class action lawsuit against Ortho-McNeil Pharmaceutical, Inc., Johnson & Johnson, and Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Between the cases we’ve evaluated and the extensive investigation we have performed, the evidence appears overwhelming that the dangers of Ortho-McNeil’s Patch are occurring in young women at a staggering, and quite frankly, alarming rate.
– Michael London, Lead Attorney